Gracell Biotechnologies Inc - ADR

NASDAQ:GRCL  
14.41
+0.10 (+0.70%)
Earnings Announcements

Gracell Biotechnologies Reports Qtrly Loss Per Share $0.05

Published: 05/17/2021 12:24 GMT
Gracell Biotechnologies Inc - ADR (GRCL) - Gracell Biotechnologies Reports First Quarter 2021 Unaudited Financial Results and Provides Corporate Update.
Gracell Biotechnologies Inc - Qtrly Loss per Share $0.05.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.